Citation Tools

Download PDFPDF
AB0496 Corticosteroid Use across 52 Weeks of Belimumab Therapy in SLE Patients with High Disease Activity: Combined Analyses from the BLISS Trials

Download to a citation manager

Cite this article as:
Van Vollenhoven R, Petri M, Wallace D, et al
AB0496 Corticosteroid Use across 52 Weeks of Belimumab Therapy in SLE Patients with High Disease Activity: Combined Analyses from the BLISS Trials